These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31919326)

  • 1. [Trimethylamine-N-oxide and cardiovascular events in chronic kidney disease].
    Dai Q; Zhang H; Liu Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Nov; 44(11):1294-1299. PubMed ID: 31919326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.
    Kim RB; Morse BL; Djurdjev O; Tang M; Muirhead N; Barrett B; Holmes DT; Madore F; Clase CM; Rigatto C; Levin A;
    Kidney Int; 2016 May; 89(5):1144-1152. PubMed ID: 27083288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
    Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
    Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of gut-dependent molecule trimethylamine N-oxide as a novel target for the treatment of chronic kidney disease.
    Pan S; Zhao D; Duan S; Chen X
    Int Urol Nephrol; 2023 Jul; 55(7):1747-1756. PubMed ID: 36797553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.
    Missailidis C; Hällqvist J; Qureshi AR; Barany P; Heimbürger O; Lindholm B; Stenvinkel P; Bergman P
    PLoS One; 2016; 11(1):e0141738. PubMed ID: 26751065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of Trimethylamine-N-Oxide in Chronic Kidney Disease: Contribution of Decreased Glomerular Filtration Rate.
    Pelletier CC; Croyal M; Ene L; Aguesse A; Billon-Crossouard S; Krempf M; Lemoine S; Guebre-Egziabher F; Juillard L; Soulage CO
    Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31683880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased circulating trimethylamine N-oxide contributes to endothelial dysfunction in a rat model of chronic kidney disease.
    Li T; Gua C; Wu B; Chen Y
    Biochem Biophys Res Commun; 2018 Jan; 495(2):2071-2077. PubMed ID: 29247650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota-derived trimethylamine N-oxide is associated with the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease: a systematic review and dose-response meta-analysis.
    Li Y; Lu H; Guo J; Zhang M; Zheng H; Liu Y; Liu W
    Ann Med; 2023 Dec; 55(1):2215542. PubMed ID: 37246850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Trimethylamine N-Oxide Levels Are Associated with Poor Kidney Function in People with Type 2 Diabetes.
    Kalagi NA; Thota RN; Stojanovski E; Alburikan KA; Garg ML
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimethylamine-N-Oxide Aggravates Kidney Injury via Activation of p38/MAPK Signaling and Upregulation of HuR.
    Lai Y; Tang H; Zhang X; Zhou Z; Zhou M; Hu Z; Zhu F; Zhang L; Nie J
    Kidney Blood Press Res; 2022; 47(1):61-71. PubMed ID: 34788763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiota-Dependent Trimethylamine
    Hsu CN; Lu PC; Lo MH; Lin IC; Chang-Chien GP; Lin S; Tain YL
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30469463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study.
    Mafune A; Iwamoto T; Tsutsumi Y; Nakashima A; Yamamoto I; Yokoyama K; Yokoo T; Urashima M
    Clin Exp Nephrol; 2016 Oct; 20(5):731-739. PubMed ID: 26676906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimethylamine-
    Zheng Y; Tang Z; You L; Wu Y; Liu J; Xue J
    Ren Fail; 2020 Nov; 42(1):580-586. PubMed ID: 32576072
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolic Activation of Flavin Monooxygenase-mediated Trimethylamine-N-Oxide Formation in Experimental Kidney Disease.
    Prokopienko AJ; West RE; Schrum DP; Stubbs JR; Leblond FA; Pichette V; Nolin TD
    Sci Rep; 2019 Nov; 9(1):15901. PubMed ID: 31685846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysbiosis-Related Advanced Glycation Endproducts and Trimethylamine N-Oxide in Chronic Kidney Disease.
    Taguchi K; Fukami K; Elias BC; Brooks CR
    Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34069405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice.
    Zhang W; Miikeda A; Zuckerman J; Jia X; Charugundla S; Zhou Z; Kaczor-Urbanowicz KE; Magyar C; Guo F; Wang Z; Pellegrini M; Hazen SL; Nicholas SB; Lusis AJ; Shih DM
    Sci Rep; 2021 Jan; 11(1):518. PubMed ID: 33436815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between serum trimethylamine-
    Hu C; Zhang Y; Bi X; Yao L; Zhou Y; Ding W
    Ren Fail; 2022 Dec; 44(1):1669-1676. PubMed ID: 36217682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with Gac Fruit Extract and Probiotics Reduces Serum Trimethylamine N-Oxide in Chronic Kidney Disease Rats.
    Kamkang P; Rattanachaisit P; Anegkamol W; Taweevisit M; Sapwarobol S; Tumwasorn S; Chuaypen N; Dissayabutra T
    Nutrients; 2024 Sep; 16(17):. PubMed ID: 39275312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased Kidney Function Is Associated with Enhanced Hepatic Flavin Monooxygenase Activity and Increased Circulating Trimethylamine
    Johnson C; Prokopienko AJ; West RE; Nolin TD; Stubbs JR
    Drug Metab Dispos; 2018 Sep; 46(9):1304-1309. PubMed ID: 29915157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibition.
    Lee J; Lee J; Kim K; Lee J; Jung Y; Hyeon JS; Seo A; Jin W; Weon B; Shin N; Kim S; Lim CS; Kim YS; Lee JP; Hwang GS; Yang SH
    Kidney Int; 2024 Jun; 105(6):1239-1253. PubMed ID: 38431216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.